Re: Where's the FDA as the bodies pile up? FDA WARNINGS ON SILVER CRAP!

a_weisman_at_yahoo.com
Date: 01/29/05 

Date: 29 Jan 2005 06:33:29 -0800

Here's the FDA:

Between October 1993 and September 1994, the FDA issued warn­ing
letters to five
colloidal silver marketers::

* Higher Education Library Publications (H.E.L.P.), of
S­pringfield, Utah,
was ordered to stop claiming that its colloidal silver produ­ct was
effective as
a natural antibiotic and might be effective against cancer,
­genito-urinary
diseases, tuberculosis, and AIDS.
* Nutrition, Inc., of Arvada, Colorado, was ordered to s­top
stating or
implying that its Silvicidal, when administered orally or
in­travenously, was
nontoxic, FDA-approved, and was a broad-spectrum antibiotic ­that
killed
bacteria and all virus and fungal infections. In addition, i­t was
falsely
claimed to be effective against a long list of specific dise­ases.
* Reseau International of Cincinnati, Ohio was ordered t­o stop
claiming
that its colloidal silver product was a "natural antibiotic ­and
anti-inflammatory immune system stimulant" and that it was e­ffective
against
cancer, staph, strep, influenza, general body infections,
in­flammation,
impaired immune system, fungus toxicity, tonsillitis, Menier­e's
symptoms,
whooping cough, shingles, syphilis, cholera, and malaria. Th­e
labeling also
stated that colloidal silver could cause major growth stimul­ation of
human
tissues and can regenerate
* Silverado Inc., of Bountiful, Utah, was warned to stop­ making
false
claims that its colloidal silver product was effective as an­
antibiotic,
anti-inflammatory, anti-viral, and anti-fungal agent and tha­t it
could
stimulate the immune system.
* Unic, of Carmichael, California, was ordered to stop c­laiming
that its
colloidal silver product was effective against many diseases­ and
could heal
burn-damaged tissue without scarring.

In October 1996, the FDA proposed to ban the use of colloida­l silver
or silver
salts in over-the-counter products [7]. A Final Rule banning­ such use
was
issued on August 17, 1999 and became effective September 16t­h. The
rule applies
to any nonprescription colloidal silver or silver salt produ­ct
claimed to be
effective in preventing or treating any disease [8]. Silver ­products
can still
be sold as "dietary supplements" provided that no health cla­ims are
made for
them. During 2000, the FDA issued warnings to more than 20 c­ompanies
whose Web
sites were making illegal therapeutic claims for colloidal s­ilver
products.

In 2000, the Federal Court of Australia banned Vital Earth C­ompany
Pty Limited
and its director Darryl John Jones from falsely representing­ that the
colloidal
silver produced by their "Vital Silver 3000 Zapper," "Vital ­Silver
2000
Automatic" and "Vital Silver 2000":

* Can kill all disease-causing bacteria, fungi and virus­ within
six minutes
of contact
* Has no harmful side effects; that colloidal silver cou­ld be
used as an
antibiotic for all the acquired diseases of active AIDS
* Is effective with more than 650 different pathogenic b­acteria
and virus
types
* Has been used successfully against diseases including ­AIDS,
cholera,
diabetes, leprosy, leukemia, lupus, skin cancer, syphilis an­d
whooping cough.

The company was also ordered to pay AUS$9000 in costs and to­ provide
refunds
[9].

In 2001, the FTC obtained consent agreements with two compan­ies:

* Robert C. Spencer and Lisa M. Spencer, doing business ­as Aaron
Company
(Palm Bay, Florida). Colloidal silver has been medically pro­ven to
kill over
650 disease-causing organisms in the body and is effective i­n curing
diseases
ranging from cancer and multiple sclerosis to HIV/AIDS [10].
* ForMor, Inc., doing business as ForMor International, ­and its
president,
Stan Gross (Birmingham, Alabama) agreed not to make unsubsta­ntiated
claims that
colloidal silver is effective in treating over 650 infectiou­s
diseases, has no
adverse side effects, and is effective against arthritis, bl­ood
poisoning,
cancer, cholera, diphtheria, diabetes, dysentery, gonorrhea,­ herpes,
influenza,
leprosy, lupus, malaria, meningitis, rheumatism, shingles, s­taph
infections,
strep infections, syphilis, tuberculosis, whooping cough, an­d yeast
infections
[10].

In 2002, the FTC obtained a consent agreement with Kris Plet­schke,
doing
business as Raw Health, agreed to stop making unsubstantiate­d claims
that its
colloidal silver product could treat or cure 650 different d­iseases;
eliminate
all pathogens in the human body in six minutes or less; and ­is
medically proven
to kill every destructive bacterial, viral, and fungal organ­ism in
the body,
including anthrax, Ebola, Hanta, and flesh-eating bacteria [­12].

In 2002, the Australian Therapeutic Goods Administration ame­nded its
rules so
that water-treatment products containing substances like col­loidal
silver for
which therapeutic claims are made must meet the requirements­ of
medicines
included in the Australian Register of Therapeutic Goods. Th­is means
that such
products can no longer be legally marketed without proof tha­t they
are safe and
effective for their intended purpose. The amendment was base­d on
clnclusions
that:

* There is little evidence to support therapeutic claims­ made for
colloidal
silver products;
* The risk to consumers of silver toxicity outweighs the­ value of
trying an
unsubstantiated treatment, and bacterial resistance to silve­r can
occur
* Efforts should be made to curb the illegal availabilit­y of
colloidal
silver products, which is a significant public health issue ­[11] .

brent wrote:
> Webmaster Note: Please copy and distribute these two FDA articles far
> and wide. You should especially copy and distribute Dr. Flick's
silver
> bibliography below. Sending multiple copies to the FDA and your
> elected public servants is important since the FDA (to whom we pay
> untold millions to research and investigate) alleges: "FDA is not
> aware of any substantial scientific evidence that supports the safe
> and effective use of colloidal silver ingredients or silver salts for
> any animal disease condition." ('animal' includes humans?) and "FDA
is
> not aware of any body of data that supports the use of colloidal
> silver for the various conditions listed in the labeling used with
> currently marketed products." They, apparently have not investigated
> the scientific and medical research referenced in the following
> bibiography. It is of further interest that the FDA promises to
> investigate and prosecute any silver colloid maker/seller/distributor
> on the basis of LABELING (marketing; i.e., via commerce clause)
alone.
> Therefore silver colloid is a non-issue whether one uses it or not -
> especially since extensive research data really does exist.
> SILVER COLLOID BIBLIOGRAPHY
> prepared by Dr. A. Bart Flick
> 1. Addicks, L. et al.: Silver in Industry, Reinhold Pub. Corp., NY
> 401-450, 584-597 (1940). Extensive bibliography on silver for water
> purification.
> 2. Akiyama, H. and Okamoto, S., Prophylaxis of indwelling urethral
> catheter infection: clinical experience with a modified Foley
catheter
> and drainage system, J. Urol., 121, 40, 1979.
> 3. Avakyan, Z.A., Comparative toxicity of heavy metals for certain
> microorganisms, Microbiology, 36, 366, 1967.
> 4. Baenziger, N.C., Description of the structure of three
> silver-containing drug complexes, First International Conference on
> Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 5. Barranco, S.D. and Colmano, G., Electrical Inhibition of
> Staphlococcus aureus, Virginia Medical, 646, 1976.
> 6. Barranco, S.D., Spadaro, J.A., Berger, T.J., and Becker, R.O., In
> vitro effect of weak direct current on staphlococcus aureus, Clinical
> Orthopaedics, 100, 250, 1974.
> 7. Becker, R.O., Electrical treatment of osteomyelitis, Surgery of
the
> Musculoskeletal System, Churchill Livingstone, New York, 1983, 4, 10-
> 197.
> 8. Becker, R.O., The effect of electrically generated silver ions on
> human cells, First International Conference on Gold and Silver in
> Medicine, Bethesda, MD, May 13-14, 1987.
> 9. Becker, R.O., Effect of anodally generated silver ions on
> fibrosarcoma cells, Electro- and Magnetobio., 11, 57, 1992.
> 10. Becker, R.O. and Esper, C., Electrostimulation and undetected
> malignant tumors, Clin. Orthop., 161, 336, 1981.
> 11. Becker, R.O. and Spadaro, J.A., Treatment of Orthopedic
Infections
> with electrically generated silver ions, J. Bone Jt. Surgery., 60-A,
> 871, 1978.
> 12. Benvenisty, A.I., Tannenbaum, G., Ahlborn, T.N., Fox, C.L.,
Modak,
> S., Sampath, L., Reemtsma, K. and Nowygrod, R., Control of prosthetic
> bacterial infections: evaluation of an easily incorporated, tightly
> bound, silver antibiotic PTFE graft, J. Surg. Res., 44,1, 1988.
> 13. Berger, T.J., Spadaro, J.A., Chapin, S.E., and Becker, R.O.,
> Electrically generated silver ions: quantitative effects on bacterial
> and mammalian cells, Antimicrob. Agents Chemother., 9, 357, 1976.
> 14. Berger, T.J., Spadaro, J.A., Bierman, R., Chapin, S.E., and
> Becker, R.O., Antifungal properties of electrically generated
metallic
> ions, Antimicrob. Agents Chemother., 10, 856, 1976.
> 15. Block, Seymour, Ed.: Disinfection, Sterilization and
Preservation,
> Chapter 18; Lea & Febiger & Co., Philadelphia, 3rd Ed (1983).
> Extensive bibliography.
> 16. Bolton, L., Foleno, B., Means, B., and Petrucelli, S.,
> Direct-current bactericidal effect on intact skin, Antimicrob. Agents
> Chemother., 18, 137, 1980.
> 17. Bolton, M., The effects of various metals on the growth of
certain
> bacteria, Am. Phys., ?, 174, ?.
> 18. Bragg, P.D. and Rainnie, D.J., The effect of silver ions on the
> respiratory chain of Escherichia coli, Can. J. Microbiol., 20, 883,
> 1974.
> 19. Buckley, W.R.: Localized Argyria, Arch. Dermatol. 88: 531-539,
> 1963.
> 20. Bult, A., Silver sulfanilamides and related compounds for
> dermatological application, First International Conference on Gold
and
> Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 21. Burke, J.F., and Bondoc, C.C., Combined burn therapy utilizing
> immediate skin allografts and 0.5% AgNO3, Arch. Surg., 97, 716, 1968.
> 22. Burleson, R., and Eiseman, B., Mechanisms of antibacterial effect
> of biologic dressings, Ann. Surg., 177, 181, 1973.
> 23. Burleson, R., and Eiseman, B., Effect of skin dressings and
> topical antibiotics on healing of partial thickness skin wounds in
> rats, Surg. Gynecol. Obstet., 136, 958, 1973.
> 24. Butts, A., The chemical properties of silver, Silver-Economics,
> Metallurgy, and Use, ed. Butts, A., Krieger, Huntington, NY 1975,
123.
> 25. Carr, H.S., Wlodkowski, T.J., Rosenkranz, H.S.,
> Silver-sulfadiazine: in vitro antibacterial activity, Antimicrob.
> Agents Chemother., 4, 585, 1973.
> 26. Chu, C.S., McManus, A.T., Okerberg, C.V., Mason, A.D., and
Pruitt,
> B.A., Weak direct current accelerates split-thickness graft healing
on
> tangentially excised second-degree burns, J. Burn Care Rehab., 12,
> 285, 1991.
> 27. Chu, C.S., McManus, A.T., Mason, A.D., Okerberg, C.V. and Pruitt,
> B.A., Multiple graft harvestings from deep partial-thickness scald
> wounds healed under the influence of weak direct current, J. Trauma,
> 30, 1044, 1990.
> 28. Chu, C.C., Tsai, W.C., Yao, J.Y., and Chiu, S.S., Newly made
> antibacterial braided nylon sutures. 1. In vitro qualitative and in
> vivo preliminary biocompatibility study, J. Biomed. Mater. Res., 21,
> 1281, 1987
> 29. Cieszynski, T., Influence of negative electricity on infected
> callus and osteitis, Acta Morphologica Acad. Sci. Hung., 15, 309,
> 1967.
> 30. Collinge, C.A., Goll, G., Seligson, D. and Easly, K.J., Pin tract
> infections: silver vs. uncoated pins. Orthopedics, 17, 445, 1994.
> 31. Colmano, G., Medical Applications of monomolecular films of
> silver, gold and other metals, International Conference on Gold and
> Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 32. Colmano, G., and Barranco, S.D., Inhibition of staphlococcus
> aureus on a contaminated electrode in the femur of the rabbitt by low
> electrical current and its relation to stress, Biophys. J., 15, 28a,
> 1975.
> 33. Colmano, G., and Barranco, S.D., Staphlococcus aureus inhibition
> by low direct current on silver electrodes in the femur of rabbits.
> Fifty- third Annual meeting of the Virginia Academy of Science,
> Harrisonburg, VA, May 6-9, 1975.
> 34. Colmano, G., Edwards, S.S., Lesch, T.E., and Barranco, S.D.,
> Control of Staphlococcus aureus osteomyelitis by microampere
> activation of metal ions in monomolecular films on stainless steel
> pins, Fifty-Third Annual Meeting of the Virginia Academy of Science,
> Harrisonburg, VA, May 6- 9,
> 35. Colmano, G., Edwards, S.S., and Barranco, S.D. Activation of
> antibacterial silver coatings on surgical implants by direct current:
> preliminary studies in rabbits, _., 41, 964, 1980.
> 36. Colmano, G. , Edwards, S.S., Fainter, L.K. and Barranco, S. D.,
> Electronmicrographs of silver and stainless steel surgical implants
> coated with silver compounds to control S. Aureus by direct current
> activation, Twenty-eighth Annual ORS, New Orleans, LA, January 19-21,
> 1982.
> 37. Colmano, G., Edwards, S.S. and Barranco, S.L., Effects of low
> direct current on monomolecular layers of metal stearates coating
> electrodes in bacterial cultures and surgical implants, Symposium
URSI
> "Ondes Electro-magnetiques et Biologie", Jouy-en-Josas, Juillet,
1980,
> 149.
> 38. Colmano, G., Fainter, L.K., Edwards, S.S., and Barranco, S.D.,
SEM
> of S. aureus on current-activated surgical pins coated with silver
and
> silver stearate monolayers, Second Annual BRAGS, Oxford, U.K., Sept.
> 20-22, 1982.
> 39. Cowlishaw, J., Spadaro, J.A., Becker, R.A., Inhibition of enzyme
> induction in e. coli by anadoc silver, J. Bioelectricity, 1, 295,
> 1982.
> 40. Crannell, M.Y., Silver in Medicine, Silver-Economics, Metallurgy
> and Use, ed. Butts, A., Krieger, Huntington, NY, 1975, 227.
> 41. Cullen, J.M. and Spadaro, J.A., Axonal regeneration in the spinal
> cord: a role for applied electricity, J. Bioelectricity, 2, 57, 1983.
> 42. Danscher, G., Rytter Norgaard, J.O., and Baatrup, E.,
> Autometallography: tissue metals demonstrated by a silver enhancement
> kit, Histochemistry, 86, 465, 1987.
> 43. Deitch, E.A., Marino, A.A., Gillespie, T.E., and Albright, J.A.,
> Silver-nylon: a new antimicrobial agent, Antimicrob. Agents
> Chemother., 23, 356, 1983.
> 44. Deitch, E . A. , Marino, A. A . , Malaleonok, V. , and Alb richt,
> J . A . , Silver nylon cloth: in vitro and in vivo evaluation of
> antimicrobial activity, J. Trauma, 27, 301, 1987.
> 45. Doherty, P.J. and Williams, D.F., The response of cells and
> cellular enzymes to silver, presented at Biointeractions '87,
> Cambridge, U.K., July 6-8, 1987, 38.
> 46. Conahue, G.F., The analytical chemistry of silver,...
> 47. Eichhom, G.L., Shin, Y.A., Butzow, J.J., Clark, P., and Tarien,
> E., Interaction of metal ions with biological systems, with special
> reference to silver and gold, First International Conference on Gold
> and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 48. Ellerman-Eriksen, S., Rungby, J., and Morgensen, S.C.,
> Autointerference in silver accumulation in macrophages without
> affecting phagocytic, migratory or interferon-producing capacity,
> Virchows Arch., B. 53, 243, 1987.
> 49. Ersek, R.A., and Navarro, J.A., Maximizing wound healing with
> silver impregnated porcine xenograft, Today's OR Nurse, 12, 4, 1990.
> 50. Ersek, R.A., and Denton, D.R., Cross-linked silver-impregnated
> skin for burn wound management, J. Burn Care Rehabil., 9, 476, 1988.
> 51. Ersek, R.A., Gadaria, U., and Denton, D.R., New natural wound
> dressing, Phys. Ther. Forum, 5, 1, 1986.
> 52. Ersek, R.A., and Denton, D.R., Silver-impregnated porcine
> xenograft for damaged or missing skin, Contemp. Surg., 23, 83, 1983.
> 53. Ersek, R.A., and Denton, D.R., Treatment of skin graft donor
sites
> using silver-impregnated porcine xenograft, Contemp. Orthop., 12, 27,
> 1986.
> 54. Ersek, R. A. and Denton, D . R. , Silver-impregnated porcine
> xenografts for treatment of meshed autografts, Plast. Surg., 13, 482,
> 1984.
> 55. ErsekR.A. and Lorio, J., The most indolent ulcers of the skin
> treated with porcine xenografts and silver ions, Surg. Gynecol.
> Obstet., 158, 431, 1984.
> 56. Ersek, R.A., and Denton, D.R., Rhinophyma: treatment with
> electrocautery and silver-impregnated porcine xenograft, Plast.
> Reconstr. Surg., 74, 269, 1984.
> 57. Ersek, R.A., and Hachen, H.J., Porcine xenografts in the
treatment
> of pressure ulcers, Ann. Plast. Surg., 5, 464, 1980.
> 58. Ersek, R.A., and Denton, D.R., Nail bed avulsions treated with
> porcine xenografts, J. Hand Surg., 10A, 152, 1985.
> 59. Ersek, R.A., Denton, D.R., Surak, G.M., and Peters, C.W.,
> Treatment of spider bites with silver-impregnated porcine xenografts,
> Texas Med., 81, 32, 1985.
> 60. Falcone, A.E., and Spadaro, J.A., Inhibitory effects of
> electrically activated silver material on cutaneous wound bacteria,
> Plast. Reconstruc. Surg., 77, 455, 1986.
> 61. Flick, A.B., Clinical application of electrical silver
> iontophoresis, First International Conference on Gold and Silver in
> Medicine, Bethesda, MD, May 13-14, 1987.
> 62. Flowers III, R.H., Schwenzer, K.J., Kopel, R.F., Fisch, M.J.,
> Tucker, S.I., and Farr, B.M., Efficacy of an attachable subcutaneous
> cuff for the prevention of intravascular catheter-related infection.
> JAMA, 261, 878, 1989.
> 63. Fox, C.L., Jr.: Silver Sulfadiazine - A New Topical Therapy for
> Pseudomonas in Burns; Arch. Surg., 96, 184-188 (1968)
> 64. Fox, C.L. and Modak, S.M., Mechanism of silver sulfadiazine
action
> on burn wound infections, Antimicrob. Agents Chemother., 5, 582,
1974.
> 65. Fox, C.L. and Quintiliani, R., Uses of silver sulfadiazine in
> burns and surgical wounds, Inf. in Surg., 13, 1982.
> 66. Furst, A., Schlauder, M.C.: Inactivity of Two Noble Metals as
> Carcinogens; Jour. Environmental Pathology and Toxicology, 1, 51-57
> 67. Geddes, L.A., and Baker, L.E., chlorided silver electrodes, Med.
> Res. Eng., Third quarter, 33, 1967.
> 68. Golubovich, V.N., and Rabotnova, I.L., Kinetics of growth
> inhibition in Candida utilis by silver ions, Microbio., 43, 948,
1974.
> 69. Gristina, A.G., and Costerton, J.W., Bacterial adherence to
> Biomaterials and tissue, J. Bone Jt. Surg., 67-A, 264, 1985.
> 70. Gruen, L.C., Interaction of amino acids with silver ions,
Biochim.
> Biophys. Acta, 386, 270, 1975.
> 71. Haeger, K., Preoperative treatment of leg ulcers with silver
spray
> and aluminum foil, Acta Chir. Scand., 125, 32, 1963.
> 72. Hall, R.E., Bender, G., and Marquis, R.E., In vitro effects of
ion
> intensity direct current generated silver on eukaryotic cells, J.
Oral
> Maxillofac. Surg., 46, 128, 1988.
> 73. Hall, R.E., Bender, G., and Marquis, R.E., Inhibitory and cidal
> antimicrobial actions of electrically generated silver ions, J. Oral
> Maxillofac. Surg., 45, 779, 1987.
> 74. Halsted, W.S., Ligature and suture material: the employment of
> fine silk in preference to catgut and the advantages of transfixion
of
> tissues and vessels in control of hemorrhage - also an account of the
> introduction of gloves, gutta-percha tissue and silver foil, JAMA,
LX,
> 1119, 1913.
> 75. Harker, J.M., and Hunter, D.: Occupational Argyria, Br J.
> Dermatol. 47: 441-455, 1935.
> 76. Harrison, H.N., Pharmacology of Sulfadiazine silver, Arch. Surg.,
> 114, 281, 1979.
> 77. Haynes, J.L., and Schulte, T.H., Antibacterial silver surfaces
and
> assessment of needs and opportunities for clinical devices, First
> International Conference on Gold and Silver in Medicine, Bethesda,
MD,
> May 13-14, 1987.
> 78. Hendry, A.T., and Stewart, I.O., Silver-resistant
> enterobacteriaceae from hospital patients, Can. J. Microbiol., 25,
> 915, 1979.
> 79. Holder, I.A., Knoll, C.A., and Wesselman, J., Norfloxacin and
> silvernorfloxacin as topical antimicrobial agents: results of in
vitro
> susceptibility testing against bacteria and Candida sp. isolated from
> burn patients, First International Conference on Gold and Silver in
> Medicine, Bethesda, MD, May 13-14, 1987.
> 80. Janz, G.J., and Ives, D.J.G., Silver, silver chloride electrodes,
> Ann. N.Y. Acad. Sci., ?, 210, ?.
> 81. Jono, K., Yamano, T., Fujmoto, T., and Eguchi, Y.: Bactericidal
> Action of Active Carbon Coated With Silver and Its Application to
> Water Purifiers; J. Takeda Research Lab., 33, 9-18, (1974).
> 82. Jones, A.M., and Bailey, J.A.: Effect of Silver from Cloud
Seeding
> on Rabbits; Water, Air and Soil Pollution, 3/3, 353-363 (1974).
> 83. Kahn, J., Acetic acid iontophoresis for calcium deposits, Phys.
> Ther., 57, 658, 1977.
> 84. Kahn, J., Calcium iontophoresis in suspected myopathy, Phys.
Ther.
> 85. Kirchoff, D.A.: Localized Argyria After a Surgical Endodontic
> Procedure, Oral Surg. 32: 613-617, 1971.
> 86. Kramer, S.J., Spadaro, J.A. and Webster, D.A., Antibacterial and
> osteoinductive properties of demineralized bone matrix treated with
> silver, Clin. Orthop. Rell. Res., 161, 154, 1981.
> 87. Kul'skii, L.A., Savluk, O.S., Moroz, O.G., and Kornievakay, L.P.:
> Disinfection and Conservation of Water with Silver (Russian),
Aktualne
> Vodoprovedeniye Sanitarniy Mikrobiologii, 111 (1973).
> 88. Landeen, L.K., Yahya, M.T., Kutz, S.M., Gerba, C.P.:
> Microbiological Evaluation of Copper: Silver Disinfection Units for
> Use in Swimming Pools; Water Science Tech., 21, 3, 267-270 (1989).
> 89. Lee, J.V., Hibberd, M.L. and Stanley, S.C.: A Comparison of the
> Biocidal Properties of Silver Ions and Chloride Against Legionella
> Species; PHLS Centre for Applied Microbiology and Research, Porton
> Down, Salisbury SP4 OJG, England, DD3/2 AGREPORT (1989).
> 90. McHugh, G.L., Moellering, R.C., Hopkins, C.C. and Swartz, M.N.,
> Salmonella typhimurium resistant to silver nitrate, chloramphenicol
> and ampicilin, Lancet, ii, 235, 1975.
> 91. McNamara, A. and Williams, D.F., Scanning electron microscopy of
> the metal-tissue interface, Biomaterials, 3, 160, 1982.
> 92. MacKeen, P.C., Person, S., Warner, S.C., Snipes, W., and Stevens,
> S.E., Silver-coated nylon fiber as an antibacterial agent,
Antimicrob.
> Agents Chemother., 31, 93, 1987.
> 93. Madden, M.R., Nolan, E., Finkelstein, J.L., Yurt, R.W., Smeland,
> J., Goodwin, C.W., Hefton, J., and Staiano-Coico, L., Comparison of
an
> occlusive and semi-occlusive dressing and the effect of the wound
> exudate upon keratinocyte proliferation, J. Trauma, 29, 924, 1989.
> 94. Mahan, J., Seligson, D., Henry, S.L., Hynes, P., and Dobbins, J.,
> Factors in pin tract infections, Orthopedics, 14, 305, 1991.
> 95. Maki, D.G., Cobb, L., Garman, J.K., Shapiro, J.M., Ringer, M.,
and
> Helgerson, R.B., An attachable silver-impregnated cuff for prevention
> of infection with central venous catheters: a prospective randomized
> multicenter trial, Am. J. Med., 85, 307, 1988.
> 96. Marchant, R.E., Miller, K.M. and Anderson, J.M., In vivo
Leukocyte
> interactions with Biomer, J. Biomed. Mater. Res., 18, 1169, 1984.
> 97. Marino, A.A., Malakonok, V., Albright, J.A., Deitch, E.A. and
> Specian, R.D., Electrochemical properties of silver-nylon fabrics, J.
> Electrochem. Soc., 132, 68, 1985.
> 98. Marino, A.A., Electromagnetic fields, cancer and the theory of
> neuroendocrine related promotion, Bioelectrochem. Bioenergetics, 29-
> 255, 1993.
> 99. Marino, A.A., Deitch, E.A., Malakanok, V., Albright, J.A., and
> Specian, R. D., Electrical augmentation of the antimicrobial activity
> of silver-nylon fabrics, J. Biol. Phys., 12, 93, 1984.
> 100. Marino, A.A., Malakanok, V., Deitch, E.A., and Albright, J.,
> Electrical properties of silver-nylon, Third Annual BRAGS, San
> Francisco, CA, Oct. 2-5, 1983, 36.
> 101. Marino, A.A., Deitch, E.A. and Albright, J.A., Electric silver
> antisepsis, IEEE Trans. Biomed. Eng., BME-32, 336, 1985.
> 102. Marino, A.A., Berger, T.J., Becker, R.O. and Spadaro, J.A., The
> effects of selected metals on marrow cells in culture, Chem. Biol.
> Interactions, 9, 217, 1974.
> 103. Marshall, J.P., and Schneider, R.P.: Systemic Argyria Secondary
> to Topical Silver Nitrate, Arch. Dermatol. 113: 1077-1079, 1977.
> 104. Mears, D.C., Electron-probe microanalysis of tissue and cells
> from implant areas, J. Bone Joint Surg., 48B, 567, 1966.
> 105. Merril, C.R., Silver-stain detection of proteins separated by
> polyacrylamide gel electrophoresis, First International Conference on
> Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 106. Modak, S.M. and Fox, F.L., Binding of silver sulfadiazine to the
> cellular components of Pseudomonas aeruginosa, Biochem. Pharmacol.,
> 22, 2391, 1973.
> 107. Modak, S.M., Sampath, L., Fox, C.L. Combined use of silver
> sulfadiazine and antibiotics topically in burn wounds as a possible
> solution to bacterial resistance, First International Conference on
> Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 108. Modak, S.M., Sampath, Lester and Fox, C.L.: Combined Use of
> Silver Sulfadiazine and Antibiotics as a Possible Solution to
> Bacterial Resistance in Burn Wounds; Jour. Burn Care, Vol. 9, No. 4,
> p. 359 (July/Aug 1988).
> 109. Modak, S.M. and Fox, C.L. Sulfadiazine silver-resistant
> Pseudomonas in burns: new topical agents, Arch. Surg., 116, 854,
1981.
> 110. Nordenstrom, B.E.W. Biokinetic impacts of structure and imaging
> of the lung: the concept of biologically closed electric circuits.
> AJR, 145, 1985, 447.
> 111. Olcott, C.T.: Experimental Argyrosis, IV, Morphological Changes
> in the Experimental Animal; Am. Jour. of Pathology, 24, 813, (1948).
> 112. Orr, M.A., Electroplating....
> 113. Owen, M.C.R.: A Case History of 30 Years of Use With Silver
> Disinfected Drinking Water; Records of EPA Public Hearing on Revised
> Primary Drinking Water Regulations held Jan. 28, 1986.
> 114. Pareilleux, A. and Sizard, N., Lethal effects of electric
current
> on Escherichia coli. Appl. Microbiol., 19, 421, 1970.
> 115. Pariser, R.J., Generalized argyria: Clinopathologic Features and
> Histochemistry, Arch. Dermatol., 114; 373-377, 1978.
> 116. Parker, W.A.: Argyria and Cyanotic Heart Disease, Am. J. Hosp.
> Pharm. 34: 287-789, 1977.
> 117. Pharmacology and Therapeutics; Pergamon Press, Series A, Vol. 1.
> 127-130 (1976).
> 118. Pifer, J.W., Fridlander, B.R., Kintz, R.T., and Stockdale, D.K.,
> Absence of toxic effects in silver reclamation workers, Scand. J.
Work
> Environ. Health, 15, 210, 1989.
> 119. Polachek, A.A., Cope, C.B., Willard, B.S., and Enns, T.:
> Metabolism of Radioactive Silver in a Patient with Carcinoid; Jour.
> Lab. and Clinical Medicine, 56, 1976-1979 (1949).
> 120. Rich, L.L., Epinette, W.W., and Wasser, W.K.: Argyria Presenting
> as Cyanotic Heart Disease, Am J. Cardiol. 30: 290, 1972.
> 121. Rode, H. de Wet, P.M. and Cywes, S., Germicidal efficacy of
> silver sulfadiazine in burn wounds. First International Conference on
> Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
> 122. Ronchese, F.: Argyrosis and Cyanosis - Melanosis and Cyanosis,
> Arch. Dermatol. 80: 277-282, 1959.
> 123. Rosenberg, B., Van Camp, L., and Krigas, T., Inhibition of cell
> division in Escherrichia coli by electrolysis products from a
platinum
> electrode, Nature, 205, 1965.
> 124. Rosenkranz, H.S. and Carr, H.S., Silver sulfadiazine: effect on
> the growth and metabolism of bacteria, Antimicrob. Agents Chemother.,
> 2, 948-951, 1972.
> 125. Rosenkranz, H. S., Coward, J.E., Wlodkowski, T.J. and Carr, H.
S.
> Properties of silver sulfadiazine-resistant enterobacter cloacae.
> Antimicrob. Agents Chemother., 5, 199, 1974.
> 126. Rosenkranz, H.S. and Rosenkranz, S., Silver sulfadiazine:
> interaction with isolated deoxyribonucleic acid, Antimicrob. Agents.
> Chemother., 2, 373, 1972.
> 127. Rosenman, K.D., Moss, A., Kon, S. Argyria: Clinical Implications
> of Exposure to Silver Nitrate and Silver Oxide; Jour. Occupational
> Med. 21, 430-435 (1979)
> 128. Ross, E.M.: Argyria Caused by Chewing of Photographic Film, N
> Engl. J. Med. 299: 798, 1963.
> 129. Rowley, B.A., and McKenna, J.M. Electrical current effects on E.
> coli growth rates (36269), P.S.E.B.M., 139, 929, 1972.
> 130. Rungby, J., Experimental argyosis: ultrastructural localization
> of silver in rat eye, Exp. Mol. Pathol., 45, 22, 1986.
> 131. Rungby, J., Exogenous silver in dorsal root ganglia, peripheral
> nerve, enteric ganglia and adrenal medulla, Acta Neuropathol.
> (Berlin), 69, 46, 1986.
> 132. Rungby, J., Ellerman-Eriksen, S. and Danscher, G., Effects of
> selenium on toxicity and ultrastructural localization of silver in
> cultured macrophages, Arch. Toxicol., 61, 40, 1987.
> 133. Rungby, J., Huffman, P., and Ellermann-Eriksen, S., Silver
> affects viability and structure of cultured mouse peritoneal
> macrophages and peroxidative capacity of whole mouse liver, Arch.
> Toxicol., 59, 408, 1987.
> 134. Savluk, O.S.: Influence of Anodically Dissolved Silver on the
> Reticuloendothelial System in Test Animals (Russian); Vodopodgotovka
I
> Ochistka Promyshlennyh Stokov, 10, 72-77 (1973).
> 135. Schaefer, A.J., K.O. and Johnson, S.M., Effect of silver
> oxide/trichloroisocyanuric acid antimicrobial urinary drainage system
> on catheter associated bacteriuria, J. Urol., 139, 69, 1988.
> 136. Shafik, A., The electrified drain. A new device for sterilizing
> the field of drainage, Int. Surg., 78, 357, 1993.
> 137. Sobotka, H., Monomolecular laters,....
> 138. Spadaro, J.A., Silver anode inhibition of bacteria, First
> International Conference on Gold and Silver in Medicine, Bethesda,
MD,
> May 13-14, 1987.
> 139. Spadaro, J.A., Antibacterial effects of silver electrodes, Third
> Ann. Conf. Eng. Med. Biol. Soc. of IEEE, 1981, 215.
> 140. Spadaro, J.A., Bioelectric stimulation of bone formation:
> methods, models and mechanisms, J. Bioelect., 1, 99, 1982.
> 141. Spadaro, J.A., Electrically stimulated bone growth in animals
and
> man. Clin. Orthop. Rel. Res., 122, 325, 1977.
> 142. Spadaro, J.A., Bone formation aterial inhibition with silver and
> other electrodes, Reconstr. Surg. Traumat. 19, 40, 1985.
> 143. Spadaro, J.A., Electrical osteogenesis - role of the electrode
> material, Electrical Prop. Bone Cartillage, ?, 189, 1979.
> 144. Spadaro, J.A., Electrically enhanced osteogenesis at various
> metal cathodes, J. Biomed. Mat. Res., 16, 861, 1982.
> 145. Spadaro, J.A. and Becker, R.O., Function of implanted cathodes
in
> electrode-induced bone growth, Med. Biol. Eng. Compuit., 17, 769,
> 1979.
> 146. Spadaro, J.A. and Becker, R.O. Some specific cellular effects of
> electrically injected silver and gold ions, Bioelectrochem.
> Bioenergetics, 3, 49, 1976.
> 147. Spadaro, J.A. and Becker, R.O., Size-specific metal complexing
> sites in native collagen, Nature, 225, 1134, 1970.
> 148. Spadaro, J.A., Berger, T.J., Barranco, S.D., Chapin, S.E., and
> Becker, R.O., Antibacterial effects of silver electrodes with weak
> direct current, Microb. Agents. Chemother., 6, 637, 1974.
> 149. Spadaro, J.A., Chase, S.E., and Webster, D.A., Bacterial
> inhibition by electrical activation of percutaneous silver implants,
> J. Biomed. Mater. Res., 20, 565, 1986.
> 150. Spadaro, J.A., Kramer, S.J., and Webster, D.A., Antibacterial
> demineralized bone matrix using silver, 28th Annual ORS, New Orleans,
> LA, Jan. 19-21, 1982.
> 151. Spadaro, J.A., Mino, D.E. and Chase, S.E., Bone formation
without
> current: The effect of electrode motion, 30th Annual ORS, Atlanta,
GA,
> Feb. 7-9, 1984, 69.
> 152. Spadaro, J.A., Mino, D.E., Chase, S.E., Werner, F.W. and Murray,
> D.G., Mechanical factors in electrode-induced osteogenesis, J.
Orthop.
> Res., 4, 37, 1986.
> 153. Spadaro, J.A., Webster, D.A., Chapin, S.E., Yuan, H.A., Murray,
> D.G. and Becker, R.O. Silver-PMMA antibacterial bone cement, 24th
> Annual ORS, Dallas, TX, Feb. 21-23, 1978, 173.
> 154. Spadaro, J.A., Webster, D.A. and Chase, S.E., Direct current
> activation of bacteriostatic silver electrodes, Third Annual BRAGS,
> San Francisco, CA, Oct. 2-5, 1983.
> 155. Spadaro, J.A., Webster, D.A., and Becker, R.O., Silver
polymethyl
> methacrylate antibacterial bone cement, Clin. Orthop. 143, 266, 1979.
> 156. Spadaro, J.A., Webster, D.A., Kovach, J. and Chase, S.E.
> Antibacterial fixation pins with silver: animal models, 30th Annual
> ORS, Atlanta, GA, Feb. 7-9, 1984, 335.
> 157. Tarr, R., Luck, J.V., Snyder, S. and Mills, B., Laboratory
> experiences with silver electrode bone stimulation, 29th Annual ORS,
> Anaheim, CA, March 8-10, 1983, 253.
> 158. Taubes, G., An electrifying possibility, Discover, 7, 23, 1986.
> 159. Thibodeau, E.A., Handelman, S.L. and Marquis, R.E., Inhibition
> and killing of oral bacteria by silver ions generated with low
> intensity direct current, J. Dent. Res., 57, 922, 1978.
> 160. Thurman, R.B., and Gerba, C.P.: The Molecular Mechanisms of
> Copper and Silver Ion Disinfection of Bacteria and Viruses; CRC
> Critical Reviews in Environmental Control, Vol 18, Issue 4 (1989).
> Extensive bibliography.
> 161. Tsai, W.C., Chu, C.C., Chin, S.S. and Yao, J.Y., In vitro
> quantitative study of newly made antibacterial braided nylon sutures,
> Surg. Gynecol. Obstet., 165, 207, 1987.
> 162. Vince, D.G. and Williams, D.F., Determination of silver in blood
> and urine by graphite furnace atomic absorption spectrometry,
Analyst,
> 112, 1627,
> 163. Vince, D.G. and Williams, D.F., Systemic distribution of metals
> following implantation, presented at Biointeractions'87, Cambridge,
> U.K., July 6-8, 1987, 40.
> 164. Wataha, J.C., Hanks, C.T. and Craig, R.G., The effect of cell
> monolayer density on the cytotoxicity of metal ions which are
released
> from dental alloys, Dent. Mater., 9, 172, 1993.
> 165. Watts, S.H., The silver bolt as a means of fixing ununited
> fractures of certain long bones. Johns Hopkins Hospital Bulletin,
> April 1904, 135.
> 166. Webster, D.A., Spadaro, J.A., Kramer, S., and Becker, R.O.,
> Silver anode treatment of chronic osteomyelitis, Clin. Orthop., 1961,
> 105, 1981.
> 167. West, H.D., Johnson, A.P., and Johnson, C.W.: The Use of
> Radioactive Silver for the Detection of Abscesses and Tumors; Jour.
> Lab. and Clinical Medicine, 34, 1976-1979 (1949).
> 168. Whalberg, Vivian: The Crede Prophylaxis; Acta Paediatrica
> Scandinavica, Supplement 295, Stockholm 1982.
> 169. Williams, D.F. The biocompatibility of silver, First
> International Conference on Gold and Silver in Medicine, Bethesa, MD,
> May 13-14, 1987.
> 170. Williams, D.F., Definitions in Biomaterials, Essevier,
Amsterdam,
> 1987.
> 171. Williams, D.F., and Doherty, P.J. and Oliver, C., The analysis
of
> inflammatory exudates in the assessment of biocompatibility,
presented
> at Biointeractions '87, Cambridge, U.K., July 6-7, 1987, 22.
> 172. Williams, R.L., Doherty, P.J., Vince, D.G., Grashoff, G.J. and
> Williams, D.F., The biocompatibility of silver, Critical Reviews in
> Biocompatibility, 5, 221, 1989.
> 173. Williams, R.L. and Williams, D.F., Albumin absorption on metal
> surfaces, Biomaterials, 1988.
> 174. Williams, R.L. and Williams, D.F., The spatial resolution of
> protein absorption on ogeneous metallic biomaterials, J. Biomed.
> Mater. Res., 23, 339, 1989.
> 175. Williams, R.L. and Williams, D.F., The effect of albumin on the
> wettability of pure metal and metal oxide surfaces, J. Colloid
> Interface Sci., 126, 596, 1988.
> 176. Wlodkowski, T.J. and Rosenkranz, H.S., Antifungal activity of
> silver sulphadiazine, Lancet, 1972, 739.
> 177. Wysor, M.S. and Zollinhofer, R.E., On the mode of action of
> silver sulfadiazine, Pathol. Microbiol., 38, 296, 1972.
> 178. Wysor, M.S. and Zollinhofer, R.E., Silver
> phosphanilamidopyrimidine, Chemother. 18, 342, 1973.
> 179. Wysor, M.S. and Zollinhofer, R.E., Reactivity of silver
> sulfadiazine and the silver uracils with the glucose oxidase of
> Aspergillus niger, Enzyme, 14, 185, 1972-73.
> 180. Wysor, M.S. and Zollinhofer, R.E., Deoxyribonucleic acid repair
> replication in Pseudomonas aeroginosa after sublethal doses of silver
> sulfadiazine, Path. Microbiol. 39, 434, 1973.
> 181. Wolcott, L.E., Wheeler, P.C., Hardwicke, H.M. and Rowley, B.A.,
> Accelerated healing of skin ulcers by electrotherapy: preliminary
> clinical results, Southern Med. J., 62, 795, 1969.
> 182. Zimmerman, R.L., Piezoelectricity and biological materials, J.
> Bioelectricity, 1, 265, 1982.
> 183. Zmener, O. and Dominguez, F., Silver accumulations in periapical
> granulomas: report of five cases using the scanning electron
> microscope, the electron microprobe and other complementary methods,
> Oral Surg. Oral Med. Oral Pathol., 65, 94, 1988.